Name: TBPH Balance Sheet - Theravance Biopharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TBPH - Theravance Biopharma, Inc.

USD | NASDAQ | Healthcare

TBPH Balance Sheet - Theravance Biopharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Cash And Short Term Investments
Cash And Equivalents	167.8	37.8	39.5	298.2	90.0	81.5	58.1	378.0	89.0	344.7	112.7	89.2	0.0	0.0	-
Restricted Cash	-	-	-	-	-	-	-	-	-	0.8	0.8	0.8	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	167.8	37.8	39.5	298.2	90.0	81.5	58.1	378.0	89.0	344.7	112.7	89.2	0.0	0.0	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	0.6	2.3	0.6	1.9	0.3	0.2	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	0.0	16.8	12.2	10.0	12.5	10.4	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	29.7	29.8	30.7	44.7	52.1	62.2	60.2	62.9	56.9	52.7	52.1	64.1	62.0	-
Current Liabilities
Accounts Payable	2.6	2.2	1.5	1.6	3.1	6.8	4.8	9.0	5.9	1.7	18.8	9.9	6.9	-	-
Non-Current Liabilities
Long Term Debt	-	-	0.0	-	616.3	619.2	455.0	454.4	223.7	-	-	-	-	-	-
Common Equity
Common Stock	0.0	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Supplementary Data
Total Debt	-	-	0.0	-	616.3	619.2	455.0	454.4	223.7	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	288.1	167.8	174.8	281.9	110.6	37.8	23.4	46.3	53.8	39.5	71.7	105.6	187.7	298.2	418.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17.9	17.9	17.2	16.8	15.3	12.1	13.2	12.2	12.5	9.8
Prepaid Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	417.6	418.5	354.7	366.3	150.3	161.1	116.5	119.3	124.3	133.5	161.7	192.0	261.3	353.5	511.7	154.7

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	5.5	5.9	6.3	6.6	7.0	7.4	7.8	8.1	8.7	9.1	9.3	9.6	12.1	11.9	11.9	12.5	13.2
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	148.3	94.1
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	23.0	24.4	25.5	26.5	27.4	28.4	29.3	31.8	35.4	36.3	37.6	38.5	39.2	40.1	40.0	41.1
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	25.3	24.9	25.2	25.8	13.8	12.3	7.5	7.7	7.9	8.1	10.0	11.6	12.1	6.9	4.9	3.3	3.2
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	472.3	485.6	415.5	426.0	343.6	354.2	356.1	362.0	371.3	382.0	413.6	446.6	538.6	607.4	763.5	360.8	355.4

Current Liabilities
Accounts Payable	1.1	2.6	2.2	1.7	2.4	2.2	1.5	1.7	1.7	1.5	2.4	1.6	2.7	1.6	5.3	3.1	1.5	3.1	8.9	10.7	6.8	6.8	6.4	10.1	6.6	4.8	8.7	3.5	5.6	9.0	3.7	3.6	5.1	5.9	5.6	6.4	3.6	1.7	5.4	7.4
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Operating Lease Liabilities Current	10.8	10.9	10.9	10.9	10.8	10.7	4.2	4.2	4.1	3.9	9.7	9.2	7.4	6.8	0.7	2.6
Accrued Expenses	8.7	12.6	10.3	7.3	5.4	7.0	7.8	5.8	4.5	6.4	6.6	5.4	5.0	10.3	7.6	7.0	9.6	12.8
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	31.8	38.3	37.4	54.6	31.5	32.1	23.4	22.9	21.7	24.8	25.4	24.5	26.2	28.7	142.1

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	624.7	621.5	-	615.9	609.5	614.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	29.8	31.8	33.7	35.6	37.3	39.1	40.8	42.4	43.8	45.2	41.1	42.5	43.8	45.4	51.4	50.6
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	0.2	0.2	0.2	0.2	0.2	0.2	0.3
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.2	0.3	0.3	1.5	1.3	1.9	5.0	4.9	5.4	5.9	7.7	7.7	7.7	1.7	1.7	2.4
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	181.7	188.8	182.8	201.2	177.6	178.6	170.5	168.3	166.4	169.0	167.5	166.5	168.0	165.6	282.9	710.6

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	1,155.2	1,156.3	1,153.3	1,149.1	1,145.1	1,141.1	1,135.6	1,131.0	1,125.7	1,122.2	1,146.9	1,172.1	1,246.5	1,295.7	1,324.2	1,410.4
Retained Earnings	(864.6)	(859.6)	(920.7)	(924.3)	(979.1)	(965.5)	(950.0)	(937.3)	(920.8)	(909.1)	(900.6)	(891.6)	(876.0)	(853.9)	(843.5)	(1,760.2)	(1,752.0)
Accumulated Other Comprehensive Income	(0.1)	0.1	0.0	(0.0)	-	0.0	0.1	(0.0)	(0.0)	(0.1)	(0.2)	(0.3)	0.1	(0.0)	(0.1)	(0.0)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	290.6	296.7	232.7	224.8	166.0	175.5	185.7	193.7	204.9	213.0	246.1	280.2	370.6	441.8	480.6	(349.8)	(351.5)
Total Equity	290.6	296.7	232.7	224.8	166.0	175.5	185.7	193.7	204.9	213.0	246.1	280.2	370.6	441.8	480.6	(349.8)	(351.5)	(338.6)